Investigation for efficacy and safety of high dose chemotherapy (MEAM) supported with auto-PBSCT for malignant lymphoma (THF 13)
Not Applicable
- Conditions
- Malignant lymphoma
- Registration Number
- JPRN-UMIN000002743
- Lead Sponsor
- TOHOKU HEMATOLOGY FORUM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1 severe bacterial infection 2 positive test for HIV antibody 3 positive test for HBs antigen 4 positive test for HCV antibody 5 angina pectoris, myocardial infarction, treatment required arrhythmia 6 interstitial pneumonia, pulmonary fibrosis, severe pulmonary emphysema
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse events, incidnece of therapy related mortality
- Secondary Outcome Measures
Name Time Method